Green Cross Labcell ranked among the top searched stocks for 4 days in the past month.


As of 11:31 AM on the 6th, Green Cross Labcell is trading at 123,200 KRW, up 3.18% from the previous day. This marks a 69.93% increase compared to December 4th. Green Cross Labcell is known as a company specializing in cell therapy research and development.

Over the past 5 days, individual investors have net sold 220,973 shares, while foreigners and institutions have net bought 102,618 shares and 107,817 shares, respectively.


On January 4th, Green Cross Labcell became a market issue with the headline 'Limit-up due to Moderna vaccine contract manufacturing rumors.'



※Source: AI Investment Assistant AI Lassi


※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing